CS is thought to be highly correlated with the overexpression of one of the three major efflux proteins (P-gp, MRP1 or BCRP) in resistant cancer cells, therefore representing a new strategy to circumvent ABC transporters-mediated MDR (Gottesman et al., 2016). The gene discussed is ABCG2; the disease is cancer.